Cisplatin binding protein

WebAug 2, 2016 · Our data reveal unexpected cisplatin binding sites on the protein surface that could have general significance: cisplatin fragments − [Pt (NH 3) 2 Cl] +, − [Pt (NH 3 )Cl 2 ], and − [Pt (NH 3) 2 (OH 2 )] 2+ … WebThe combination of adenoviruses and chemotherapy agents is a novel approach for human cancer therapeutics. A meticulous analysis between adenovirus and chemotherapeutic …

538 - Gene ResultATP7A ATPase copper transporting alpha

WebFull article: Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy Home All Journals Bioengineered List of Issues Volume 13, Issue 2 Insulin-like growth factor 2 mRNA-bindin .... Bioengineered WebMar 29, 2024 · Cisplatin binds to the copper-binding sites in the N-terminal domain of ATP7B; this binding may be an essential step of cisplatin detoxification involving copper ATPases. COX19 is necessary for the transduction of a SCO1-dependent mitochondrial redox signal that regulates ATP7A-mediated cellular copper efflux. open defect count https://thepegboard.net

Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin …

WebTherefore, the study is designed to investigate the regulatory function and mechanism of Taurine up-regulated gene 1 (TUG1) in the cisplatin resistance of CRC. qRT-PCR checked the expressions of TUG1, Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), and miR-195-5p in CRC tissues and cells. WebFeb 1, 2016 · Cisplatin owns the most tendency to plasma proteins-so that after a few hours, up to 90% of the drug is bound to protein [19, 20]. Carboplatin possesses the … WebC-terminal binding protein‑2 (CtBP2) is a transcriptional co-repressor that is associated with tumorigenesis and tumor progression. It has been reported to predict a poor prognosis in several human cancers, including esophageal squamous cell open defiance of authority called

Cells Free Full-Text Cisplatin Protein Binding Partners and …

Category:Cisplatin - The Penicillin of Cancer

Tags:Cisplatin binding protein

Cisplatin binding protein

Cancers Free Full-Text Cisplatin Relocalizes RNA Binding Protein ...

WebJun 20, 2024 · Cisplatin [ cis- diamminedichloroplatinum (II) ( cis -DDP)] is one of the most successful anticancer agents effective against a wide range of solid tumors. However, its … WebJun 15, 2024 · Wang et al. indicated that miR-17 targets c-Jun activation domain binding protein 1 (JAB1) to promote tumor growth and cisplatin (DDP) resistance of TNBC . As far as we know, chemotherapy is the standard therapeutic strategy for TNBC, and DDP is the most widely used chemotherapeutic drug for solid tumors.

Cisplatin binding protein

Did you know?

WebNational Center for Biotechnology Information WebMay 26, 2024 · Using the fluorescent cisplatin analog BODIPY-cisplatin, two-dimensional gel electrophoresis, and mass spectrometry, we identified the protein binding partners in …

WebMay 15, 2016 · We summarize the structural features of known cisplatin-protein adducts. • Key characteristics of the cisplatin modes of binding to proteins are described. • … WebThe protein binding rates (PBR) of platinum-containing agents cisplatin (CDDP), carboplatin (CBDCA) and oxaliplatin (L-OHP) have been reported as 98%, 25-50% and 98%, respectively. To investigate the protein-binding properties of albumin with cisplatin, carboplatin and oxaliplatin, inductively coupl …

WebApr 13, 2024 · HIGHLIGHTS. who: Florentine S. B. Subtil et al. from the Department of Radiotherapy and Radiooncology, Philipps-University, Marburg, Germany have published the research: Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines, in the … WebCisplatin, cis - [PtCl 2 (NH 3) 2 ], is extensively used for the treatment of testicular and ovarian cancers and increasingly against other types of solid tumors (head/neck, lung, cervical, and bladder) ( 1 , 2 , 3 , 4 ). The cytotoxic effect of cisplatin is thought to be due to attack on DNA bases and induction of apoptosis in cancer cells ( 5 , 6

WebC-terminal binding protein‑2 (CtBP2) is a transcriptional co-repressor that is associated with tumorigenesis and tumor progression. It has been reported to predict a poor …

WebJun 3, 2013 · To identify proteins that bind to cisplatin, we synthesized two different platinum-agarose conjugates, one with two amino groups and another with two chlorides attached to platinum that are available for protein binding, and conducted pull-down assays using cochlear and kidney cells. iowa recruiting 2022WebPreviously, we reported that the RNA binding protein with multiple splicing (RBPMS) is a miR-21-3p target gene in cisplatin-resistant ovarian cancer cells . RBPMS—also known as HERMES [ 16 , 17 ]—is a gene located on chromosome 8 position p12 spanning over 230 kb (30,241,924 to 30,430,508 bp) in the human genome [ 18 ]. iowa recruiting class 2022WebAug 19, 2005 · Cisplatin is a widely used anti-tumor agent for the treatment of testicular and ovarian cancers. Carboplatin is used extensively for small cell, non small cell lung cancer … iowa recruiting classWebMay 26, 2024 · Using the fluorescent cisplatin analog BODIPY-cisplatin, two-dimensional gel electrophoresis, and mass spectrometry, we identified the protein binding partners in A2780 and cisplatin-resistant A2780cis ovarian carcinoma, as well as in HCT-8 and oxaliplatin-resistant HCT-8ox colorectal cell lines. open defiance of authority wordWeb14 hours ago · The EV surface proteins as well as their expression in cells were analyzed with western blots. For the EV surface protein profiling, a coverslip coated with poly-l-lysine (PLL) to bind EVs and casein to reduce the unspecific binding of fluorescently tagged antibodies was used. The coverslip was probed with EVs and subsequently incubated … open definition meaningWebAug 24, 2024 · Systematic Identification of Proteins Binding with Cisplatin in Blood by Affinity Chromatography and a Four-Dimensional Proteomic Method Authors: Jianmei Tao Shuailong Jia Huazhong University... open defi foundationWebJun 13, 2005 · Protein binding Cisplatin does not undergo instantaneous and reversible binding to plasma protein that is characteristic of normal drug-protein binding. However, the platinum itself is capable of binding to plasma proteins, including albumin, transferrin, and gamma globulin. open delaware bank account online